UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Shared and differentiated motor skill impairments in children with dyslexia and/or attention deficit disorder: From simple to complex sequential coordination

PloS one, 2017-05, Vol.12 (5), p.e0177490-e0177490

2017

Volltextzugriff (PDF)

Fascial Manipulation® for persistent knee pain following ACL and meniscus repair

Journal of bodywork and movement therapies, 2017-04, Vol.21 (2), p.452-458

2017

Volltextzugriff (PDF)

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

Journal of clinical oncology, 2005-12, Vol.23 (35), p.9008-9021

2005

Volltextzugriff (PDF)

A Monoclonal Cytolytic T-Lymphocyte Response Observed in a Melanoma Patient Vaccinated with a Tumor-Specific Antigenic Peptide Encoded by Gene MAGE-3

Proceedings of the National Academy of Sciences - PNAS, 2001-08, Vol.98 (18), p.10290-10295

2001

Volltextzugriff (PDF)

Effect of dyssynergic defecation during pregnancy on third- and fourth-degree tear during a first vaginal delivery: a case-control study

American journal of obstetrics and gynecology, 2009-08, Vol.201 (2), p.183.e1-183.e6

2009

Volltextzugriff (PDF)

Sport injury prevention in individuals with chronic ankle instability: Fascial Manipulation® versus control group: A randomized controlled trial

Journal of bodywork and movement therapies, 2019-04, Vol.23 (2), p.316-323

2019

Volltextzugriff (PDF)

Comparison of four clinical prediction scores for the diagnosis of lower limb deep venous thrombosis in outpatients

The American journal of medicine, 2003-10, Vol.115 (6), p.436-440

2003

Volltextzugriff (PDF)

Fascial Manipulation Associated With Standard Care Compared to Only Standard Postsurgical Care for Total Hip Arthroplasty: A Randomized Controlled Trial

PM & R, 2016-12, Vol.8 (12), p.1142-1150

2016

Volltextzugriff (PDF)

The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4335-4345

2009

Volltextzugriff (PDF)

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE‐3 protein in patients with detectable metastatic melanoma

International journal of cancer, 2005-11, Vol.117 (4), p.596-604

2005

Volltextzugriff (PDF)

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

International journal of cancer, 1999-01, Vol.80 (2), p.219-230

1999

Volltextzugriff (PDF)

The Lure Technique: Replication and Refinement in a Field Setting

Psychological reports, 2015-02, Vol.116 (1), p.275-279

2015

Volltextzugriff (PDF)

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen

Immunological reviews, 2002-10, Vol.188 (1), p.33-42

2002

Volltextzugriff (PDF)

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

European journal of cancer (1990), 2003, Vol.39 (1), p.70-77

2003

Volltextzugriff (PDF)

Foot-in-the-Door Technique Using a Courtship Request: A Field Experiment

Psychological reports, 2008-10, Vol.103 (2), p.529-534

2008

Volltextzugriff (PDF)

Photoallergy to piroxicam: what should be contraindicates?

Therapie, 2013-01, Vol.68 (1), p.57

2013

Volltextzugriff (PDF)

Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors

Journal of immunotherapy (1997), 2004-03, Vol.27 (2), p.124-135

2004

Volltextzugriff (PDF)

Expression of MAGE genes in primary and metastatic cutaneous melanoma

International journal of cancer, 1995-11, Vol.63 (3), p.375-380

1995

Volltextzugriff (PDF)

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

European journal of immunology, 1995-02, Vol.25 (2), p.340-347

1995

Volltextzugriff (PDF)

Peptide-based cancer vaccines

Seminars in oncology, 2002-10, Vol.29 (5), p.494-502

2002

Volltextzugriff (PDF)

A MAGE-3 Peptide Presented by HLA-DR1 to CD4+ T Cells That Were Isolated from a Melanoma Patient Vaccinated with a MAGE-3 Protein

The Journal of immunology (1950), 2003-07, Vol.171 (1), p.219-225

2003

Volltextzugriff (PDF)

Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein

The Journal of immunology (1950), 2005-02, Vol.174 (4), p.2404-2411

2005

Volltextzugriff (PDF)

Asymptomatic Atherosclerosis in HIV-positive Patients: A Case-control Ultrasound Study

Annals of medicine (Helsinki), 1995, Vol.27 (6), p.683-685

1995

Volltextzugriff (PDF)

Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA

Cancer immunity, 2004-05, Vol.4, p.4

2004

Volltextzugriff (PDF)

1 – 25 von 337

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(329)
Mit Volltextzugriff
(294)

Publikationsform

Artikel
(336)
Buchkapitel
(1)

Sprache

Englisch
(327)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Shared and differentiated motor skill impairments in children with dyslexia and/or attention deficit disorder: From simple to complex sequential coordination

Fascial Manipulation® for persistent knee pain following ACL and meniscus repair

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

A Monoclonal Cytolytic T-Lymphocyte Response Observed in a Melanoma Patient Vaccinated with a Tumor-Specific Antigenic Peptide Encoded by Gene MAGE-3

Effect of dyssynergic defecation during pregnancy on third- and fourth-degree tear during a first vaginal delivery: a case-control study

Sport injury prevention in individuals with chronic ankle instability: Fascial Manipulation® versus control group: A randomized controlled trial

Comparison of four clinical prediction scores for the diagnosis of lower limb deep venous thrombosis in outpatients

Fascial Manipulation Associated With Standard Care Compared to Only Standard Postsurgical Care for Total Hip Arthroplasty: A Randomized Controlled Trial

Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial

The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE‐3 protein in patients with detectable metastatic melanoma

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

The Lure Technique: Replication and Refinement in a Field Setting

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

Foot-in-the-Door Technique Using a Courtship Request: A Field Experiment

Photoallergy to piroxicam: what should be contraindicates?

Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors

Expression of MAGE genes in primary and metastatic cutaneous melanoma

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

Peptide-based cancer vaccines

A MAGE-3 Peptide Presented by HLA-DR1 to CD4+ T Cells That Were Isolated from a Melanoma Patient Vaccinated with a MAGE-3 Protein

Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein

Asymptomatic Atherosclerosis in HIV-positive Patients: A Case-control Ultrasound Study

Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA

Aktive Filter

Suchergebnisse filtern